December 06, 2017
COLUMBIA, S.C. (December 6, 2017) – Nephron Pharmaceuticals Corporation (Nephron), a manufacturer of sterile inhalation and 503B outsourcing medications, today announced a $12.5 million expansion to add 36,000 square feet of manufacturing space. The new investment is expected to create 125 new jobs.
In October 2011, the company announced a $313 million facility would be constructed in West Columbia, and 600 employees would be hired by 2017. To date, Nephron has invested more than $320 million, and currently, 640 people are employed. After 20 years in Orlando, Fla., Nephron relocated its headquarters to South Carolina.
This expansion is a result of tremendous growth in both the Nephron 503B Outsourcing Division, and the existing respiratory therapy drug portfolio. The Outsourcing Division of Nephron is arguably the fastest growing 503B facility in America. 30 new products have been developed in 2017 in an effort to solve the nationwide drug shortage crisis.
“The improvement of the facility will help us meet our commitment to solve the critical problem of drug supply shortages impacting healthcare in the United States.” –Nephron Pharmaceuticals Corporation CEO Lou Kennedy
“Nephron’s commitment to growing and expanding its operations in West Columbia and investing in South Carolinians is something we are extremely grateful for. We congratulate this fantastic company on the success it’s found here, and look forward to seeing it continue for many years to come.” –Gov. Henry McMaster
“Nephron has been a longtime member of Team South Carolina, and we congratulate this great company on today’s announcement. South Carolina continues to blaze a trail in the life science industries, and announcements like this one are a further testament to that.” –Secretary of Commerce Bobby Hitt
“Nephron Pharmaceuticals has been an excellent job provider and bastion of economic prosperity for Lexington County. Their new expansion is exciting and encouraging, as it means their good work will continue to produce positive results for people in our state, as well as nationwide.” –Lexington County Council Chairman Todd Cullum
“We congratulate our friends at Nephron Pharmaceuticals on today’s announced expansion. We are proud to have the company among our flourishing industries in the Central S.C. region. Nephron’s continued growth within Lexington County speaks to the company’s dedication and commitment to the area and the future of South Carolina.” –Central S.C. Alliance Chairman Mike Brenan
FIVE FAST FACTS
About Nephron Pharmaceuticals Corporation
Nephron is a woman-owned, private manufacturer of generic respiratory medications, ophthalmic, injectable drugs, and sterile compounded outsourcing medications. The company has been inspected by the Food and Drug Administration as a sterile manufacturer of generic respiratory medications, and 503B outsourcing products to provide sterility and quality, across their portfolio. Nephron received an honorable mention as the 2017 Facility of the Year Award (FOYA) by the International Society for Pharmaceutical Engineering. All products are proudly made in the USA! For more information, please visit www.nephronpharm.com.
About Central South Carolina Alliance
The Central SC Alliance (CSCA) is a full-service professional economic development organization, founded in 1994 as a 501(c)(3) not-for-profit, public/private partnership, engaged in the recruitment of capital investment and jobs to the Central Region of South Carolina. Since inception, CSCA and its partners and allies, have attracted more than $12.7 billion in capital investment and 68,600 new jobs to the Central Region of South Carolina.
CSCA represents the City of Columbia and eight counties: Calhoun, Clarendon, Fairfield, Kershaw, Lexington, Newberry, Orangeburg and Richland. To learn more about the Central SC Alliance please visit our website at www.centralsc.org, and be sure to follow us on Twitter @Central_SC and like us on Facebook.